Nancy Y. Lee
Nancy Y. Lee | |
|---|---|
 | |
| Born | |
| Education | Barnard College University of Medicine and Dentistry of New Jersey |
| Medical career | |
| Profession | Physician |
| Field | Radiation oncology |
| Institutions | Memorial Sloan Kettering Cancer Center |
Nancy Y. Lee is a Taiwanese-born American physician and the vice-chair of the Department of Radiation Oncology in Memorial Sloan Kettering's Department of Medicine.[1]
Biography
Lee was born in Taiwan and received her bachelor's degree from Barnard College, where she majored in chemistry.[2] She earned her medical degree at the University of Medicine and Dentistry of New Jersey, and completed her residency in Radiation Oncology at the Columbia Presbyterian Medical Center.[3]
Lee has two sons and her husband is an academic ENT surgeon.[2]
Career
Lee specializes in using intensity-modulated radiation therapy (IMRT) to treat thyroid and head and neck cancers.[2][4] She served as the principal investigator for the Radiation Therapy Oncology Group (RTOG) in a national trial to refine the use of IMRT for treating nasopharyngeal cancer.[5] She is also a member of the RTOG's Head and Neck Cancer Working Group.[6]
Lee was a co-author of the Cancer Immunotherapy Guidelines for Head and Neck Cancer put forward by the Society for Immunotherapy of Cancer.[7] She sits on the editorial board of the Journal of Radiation Oncology.[8] She is also the series editor of the Practical Guides in Radiation Oncology.[9] In 2017 the American Society for Radiation Oncology designated her as a fellow.[10]
Significant publications
- Beckham, TH; Romesser, PB; Groen, AH; Sabol, C; Shaha, AR; Sabra, M; Brinkman, T; Spielsinger, D; McBride, S; Tsai, CJ; Riaz, N; Tuttle, RM; Fagin, JA; Sherman, EJ; Wong, RJ; Lee, NY (2018). "Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual Disease". Thyroid. 28 (9): 1180–1189. doi:10.1089/thy.2018.0214. PMC 6154443. PMID 30105947.
- Romesser, PB; Cahlon, O; Scher, ED; Hug, EB; Sine, K; DeSelm, C; Fox, JL; Mah, D; Garg, MK; Han-Chih Chang, J; Lee, NY (2016). "Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes". Int J Radiat Oncol Biol Phys. 95 (1): 386–395. doi:10.1016/j.ijrobp.2016.02.036. PMC 4997784. PMID 27084656..
- Lee, NY; Zhang, Q; Pfister, DG; Kim, J; Garden, AS; Mechalakos, J; Hu, K; Le, QT; Colevas, AD; Glisson, BS; Chan, AT; Ang, KK (2012). "Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi-institutional trial". Lancet Oncol. 13 (2): 172–80. doi:10.1016/S1470-2045(11)70303-5. PMC 4985181. PMID 22178121.
- Riaz, N; Hong, JC; Sherman, EJ; Morris, L; Fury, M; Ganly, I; Wang, TJ; Shi, W; Wolden, SL; Jackson, A; Wong, RJ; Zhang, Z; Rao, SD; Lee, NY (2014). "A nomogram to predict loco-regional control after re-irradiation for head and neck cancer". Radiother Oncol. 111 (3): 382–7. doi:10.1016/j.radonc.2014.06.003. PMC 5125394. PMID 24993329..
- de Arruda, FF; Puri, DR; Zhung, J; Narayana, A; Wolden, S; Hunt, M; Stambuk, H; Pfister, D; Kraus, D; Shaha, A; Shah, J; Lee, NY (2006). "Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience". Int J Radiat Oncol Biol Phys. 64 (2): 363–73. doi:10.1016/j.ijrobp.2005.03.006. PMID 15925451..
References
- ^ "Expert Highlights Avelumab Trial and Future of Immunotherapy in Head and Neck Cancer". OncLive. Retrieved October 4, 2018.
- ^ a b c "Memorial Sloan Kettering Cancer Center 2009 Annual Report". guidestar.org. p. 25. Retrieved October 4, 2018.
- ^ "Dr. Nancy Lee - Radiation Oncology - New York, NY". www.castleconnolly.com. Retrieved October 4, 2018.
- ^ Kolatch, Jonathan (April 27, 2015). "A better way to diagnose and treat cancer". The Washington Post. Retrieved October 4, 2018.
- ^ RTOG. "RTOG | Clinical Trials | Study Number 0225". Radiation Therapy Oncology Group. Retrieved October 4, 2018.[permanent dead link]
- ^ RTOG. "Head and Neck Cancer". Radiation Therapy Oncology Group. Retrieved October 4, 2018.[permanent dead link]
- ^ "Cancer Immunotherapy Guidelines - Head and Neck - Society for Immunotherapy of Cancer (SITC)". www.sitcancer.org. Retrieved October 4, 2018.
- ^ "Journal of Radiation Oncology (Editorial Board)". springer.com. Retrieved October 4, 2018.[permanent dead link]
- ^ Practical Guides in Radiation Oncology. springer.com. ISSN 2522-5715.
- ^ "American Society for Radiation Oncology members receive fellows designation". healio.com. August 3, 2017. Retrieved October 4, 2018.
External links
| International | |
|---|---|
| National | |
| Other | |
